Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Curr Opin Rheumatol. 2021 Sep 1;33(5):378–386. doi: 10.1097/BOR.0000000000000818

Table 1.

MIS-C Case Definitions

Royal College of Paediatrics and Child Health11 Centers for Disease Control12 World Health Organization13
Fever Persistent fever >38.5°C Fever >38.0°C for ≥24 hours, or report of subjective fever lasting ≥24 hours Fever > 3 days
Evidence of SARS-CoV2 Infection or Exposure SARS-CoV-2 PCR testing may be positive or negative Positive for current or recent SARS-CoV-2 infection by RT-PCR, serology, or antigen test; or COVID-19 exposure within the 4 weeks prior to the onset of symptoms Evidence of COVID-19 (RT-PCR, antigen test or serology positive), or likely contact with a person with COVID-19
Clinical Features Inflammation (neutrophilia, elevated CRP and lymphopenia)
AND
evidence of single or multi-organ dysfunction (shock, cardiac, respiratory, renal, gastrointestinal, or neurological disorder) with additional features
Laboratory evidence of inflammation
AND
Multisystem (>2) organ involvement (cardiac, renal, respiratory, hematologic, gastrointestinal, dermatologic or neurological)
Elevated markers of inflammation
AND
Two of the following:
Rash/ mucocutaneous signs;
Hypotension or shock; Features of myocardial dysfunction, pericarditis, valvulitis, or coronary abnormalities;
Coagulopathy;
Acute gastrointestinal problems
Alternative Diagnoses Exclusion of any other microbial cause No alternative plausible diagnoses No other obvious microbial cause of inflammation
Level of Care Not specified Hospitalization required Not specified